Hiroyuki Kato
Papers
3
Total Citations
17
H-Index
2
About
Hiroyuki Kato is a surgeon-researcher whose work bridges minimally invasive surgical innovation and translational oncology. His primary research areas include robotic and laparoscopic surgery for pancreatic and rectal cancers, as well as the chemopreventive potential of natural compounds in prostate cancer. Kato’s most cited work—a 2020 case report on robotic resection of an epithelial cyst in an intrapancreatic accessory spleen (12 citations)—demonstrates his commitment to advancing robotic techniques for rare pancreatic lesions. More recently, he has contributed to patient safety in rectal cancer surgery, investigating new lithotomy stirrups to prevent well-leg compartment syndrome. Notably, his 2025 study on luteolin for prostate cancer patients under active surveillance (4 citations) explores a promising dietary flavonoid as a non-toxic intervention, reflecting his interest in integrative oncology. Though his citation counts are modest, Kato’s work is characterized by its clinical relevance and attention to understudied complications. His achievements include pioneering robotic approaches for challenging pancreatic cases and contributing preliminary evidence for chemopreventive strategies in urologic oncology—a dual focus that positions him as a thoughtful clinician-scientist attentive to both surgical precision and patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3